Albert Bourla
- All
- News
- Videos
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
Pfizer Says "Already Working" On Vaccine Targeting 'Omicron' Variant
Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the 'Omicron' variant in case the current inoculation is not effective against the new strain, the US drugmaker's CEO Albert Bourla said Monday.
-
Pfizer In "Final Stages" Of Approval For Covid Vaccine In India: CEO
Pfizer CEO Albert Bourla has said that his company hope to finalise a deal with the Indian government on the approval for the company's Covid vaccine. A few days ago, NITI Aayog member D VK Paul, too, had said the same thing.
-
Pfizer CEO Says In Final Stages To Get Approval For COVID-19 Vaccine In India: Report
"I hope very soon we will finalise an agreement with the government," said Pfizer's CEO Albert Bourla
-
Pfizer CEO "Not At All" In Favour Of US Patent Waiver: Report
Pfizer CEO Albert Bourla on Thursday said he was against a US-backed proposal to waive patents on Covid-19 vaccines, saying production should be ramped up in existing facilities instead.
-
Pfizer In Talks With India Over "Expedited Approval" For COVID-19 Vaccine
Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.
-
Pfizer Chief Says Oral Drug For COVID-19 Could Be Ready Next Year: Report
Pfizer CEO Albert Bourla has said that an oral drug for treating coronavirus could be ready next year, adding that the company is working on two antivirals, an oral and an injectable.
-
Pfizer Head Says Third Vaccine Dose "Likely" Needed Within 12 Months
The head of Pfizer said in an interview aired Thursday that people will "likely" need a third dose of his company's Covid-19 shot within six to 12 months of vaccination, while elsewhere defending the relatively higher cost of the jab.
-
Pfizer Says It Can Deliver 10% More Covid Vaccines By End Of May
Pfizer has "ramped up production" of its Covid-19 vaccine and can deliver 10 percent more doses than expected to the United States by the end of May, its CEO Albert Bourla said on Tuesday.
-
"Severely Politicised": Pfizer Chief On Covid Vaccine Development
Pfizer chief executive Albert Bourla said Tuesday he understood concerns around the speed at which pharmaceutical companies have produced Covid-19 vaccines, but insisted that no corners had been cut.
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
Pfizer Says "Already Working" On Vaccine Targeting 'Omicron' Variant
Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the 'Omicron' variant in case the current inoculation is not effective against the new strain, the US drugmaker's CEO Albert Bourla said Monday.
-
Pfizer In "Final Stages" Of Approval For Covid Vaccine In India: CEO
Pfizer CEO Albert Bourla has said that his company hope to finalise a deal with the Indian government on the approval for the company's Covid vaccine. A few days ago, NITI Aayog member D VK Paul, too, had said the same thing.
-
Pfizer CEO Says In Final Stages To Get Approval For COVID-19 Vaccine In India: Report
"I hope very soon we will finalise an agreement with the government," said Pfizer's CEO Albert Bourla
-
Pfizer CEO "Not At All" In Favour Of US Patent Waiver: Report
Pfizer CEO Albert Bourla on Thursday said he was against a US-backed proposal to waive patents on Covid-19 vaccines, saying production should be ramped up in existing facilities instead.
-
Pfizer In Talks With India Over "Expedited Approval" For COVID-19 Vaccine
Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.
-
Pfizer Chief Says Oral Drug For COVID-19 Could Be Ready Next Year: Report
Pfizer CEO Albert Bourla has said that an oral drug for treating coronavirus could be ready next year, adding that the company is working on two antivirals, an oral and an injectable.
-
Pfizer Head Says Third Vaccine Dose "Likely" Needed Within 12 Months
The head of Pfizer said in an interview aired Thursday that people will "likely" need a third dose of his company's Covid-19 shot within six to 12 months of vaccination, while elsewhere defending the relatively higher cost of the jab.
-
Pfizer Says It Can Deliver 10% More Covid Vaccines By End Of May
Pfizer has "ramped up production" of its Covid-19 vaccine and can deliver 10 percent more doses than expected to the United States by the end of May, its CEO Albert Bourla said on Tuesday.
-
"Severely Politicised": Pfizer Chief On Covid Vaccine Development
Pfizer chief executive Albert Bourla said Tuesday he understood concerns around the speed at which pharmaceutical companies have produced Covid-19 vaccines, but insisted that no corners had been cut.
